Table 6 Comparison between the non-HT patients and PH patients’ risk factors.

From: A multicenter trial on the predictors of different subtypes of hemorrhagic infarction after thrombolysis

Risk factor, no, (percentage)

(Non-HT group), N = 464

Parenchymal hematoma 1, N = 14

P-value

Parenchymal hematoma 2, N = 11

P-value

Hyperlipidemia

156.0 (33.6%)

4.0 (28.6%)

0.70

3.0 (27.3%)

0.66

Diabetes mellitus

164.0 (35.3%)

5.0 (35.7%)

0.98

4.0 (28.6%)

0.94

Hypertension

288.0 (62.1%)

9.0 (64.3%)

0.87

7.0 (63.6%)

0.92

Atrial fibrillation

67.0 (14.4%)

5.0 (35.7%)

0.03*

4.0 (28.6%)

0.04*

Ischemic heart disease

57.0 (12.3%)

2.0 (14.3%)

0.82

1.0 (9.1%)

0.75

Admission hyperglycemia

140.0 (30.2%)

5.0 (35.7%)

0.66

4.0 (28.6%)

0.66

Previous TIA

131.0 (28.2%)

4.0 (28.6%)

0.98

3.0 (27.3%)

0.94

Etiology, no, (percentage)

 Large artery atherosclerosis

68.0 (14.7%)

4.0 (28.6%)

0.15

3.0 (27.3%)

0.25

 Cardio-embolism

55.0 (11.9%)

6.0 (42.9%)

0.001*

5.0 (45.5%)

0.001*

 Small artery occlusion

152.0 (32.8%)

2.0 (14.3%)

0.15

1.0 (9.1%)

0.10

 Stroke of undetermined etiology

136.0 (29.3%)

6.0 (42.9%)

0.27

5.0 (45.5%)

0.25

Co-morbid conditions on admission

 Temperature on admission, ºC, median (IQR)

37.4 (37.2–37.8)

37.7 (37.3–38.0)

0.18

37.7 (37.3–38.0)

0.14

 Cholesterol level on admission, mg/dL, median (IQR)

188.0 (181.0–237.0)

201.0 (192.0–242.0)

0.21

193.0 (190.0–240.0)

0.24

 Mean value of two points evaluation of BP within 24 h of symptoms onset, mmHg, median (IQR)

145.0 (130.0–165.0)

155.0 (135.0–165.0)

0.27

160.0 (140.0–165.0)

0.14

  1. p p value, PH parenchymal hematoma, IQR inter-quartile range. *Statistically significant at p ≤ 0.05.